dm+d
422267005
Articles
Colistimethate Sodium products: information for supporting intrathecal risk assessment
11 August 2022Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Compatibility of nebuliser solution combinations
22 June 2022Guidance on what to consider when mixing nebuliser solutions and advice on which combinations are compatible.
Lactation Safety Information
Minimal absorption from the infant's GI tract
No published evidence of safety
Small amounts in breast milk
24 September 2020